首页 > 最新文献

Brazilian Journal of Otorhinolaryngology最新文献

英文 中文
Oral and oropharyngeal mucosal lesions: clinical-epidemiological study of patients attended at a reference center for infectious diseases 口腔和口咽粘膜病变:对传染病参考中心就诊患者的临床流行病学研究
IF 2.2 4区 医学 Q2 Medicine Pub Date : 2024-02-01 DOI: 10.1016/j.bjorl.2024.101396
Clarissa Souza Mota Reis , João Gustavo Corrêa Reis , Fátima Conceição-Silva , Cláudia Maria Valete

Objective

To determine the prevalence, epidemiological profile, and clinical characteristics of Oral or Oropharyngeal Mucosal Lesions (OOPML) in patients attended at the Otorhinolaryngology Service of the Evandro Chagas National Institute of Infectious Diseases (INI-FIOCRUZ) from 2005 to 2017.

Methods

Statistical analysis of descriptive data from medical records (gender, age, education level, skin color, origin, smoking, alcoholism, HIV co-infection, time of disease evolution, first symptom, and OOPML location) was performed.

Results

Of 7551 patients attended at the service, 620 (8.2%) were included in the study. OOPML were classified into developmental anomalies (n = 3), infectious diseases (non-granulomatous n = 220; granulomatous n = 155), autoimmune diseases (n = 24), neoplasms (benign n = 13; malignant, n = 103), and unclassified epithelial/soft tissue diseases (n = 102). OOPML of infectious diseases (60.5%) and neoplasms (18.7%) were the most frequent. The predominant demographics of patients with OOPML were: males (63.5%), white (53.5%), and those in the fifth to sixth decades of life (43.3%). Local pain (18.1%) and odynophagia (15%) were the most reported first symptoms, and the most frequent OOPML sites were the palatine tonsil (28.5%), hard palate (22.7%), and tongue (20.3%). The median evolution time was three months.

Conclusions

Infectious OOPML were the most frequent, as expected in a reference center for infectious diseases, and thus, they are likely to be less frequent in general care and/or dental services. Underreporting of OOPML is possible, as oral/oropharyngeal examination is often not included in the routine medical examination. Oral cavity/oropharynx examination should be performed by specialists, such as dentists and otorhinolaryngologists, who have the expertise in identifying OOPML, even in incipient/asymptomatic cases. Given the numerous diseases in which OOPML can present, diagnosis could be facilitated by multidisciplinary teams, potentially enabling the early treatment of diseases, and thus, reduce morbidity and improve prognosis. The use of standardized medical records for oral/oropharyngeal systematic examination could provide relevant tools for differential diagnoses and information for new clinical-epidemiological studies.

Level of evidence

Level 3.

目的确定 2005 年至 2017 年期间在埃万德罗-查格斯国家传染病研究所(INI-FIOCRUZ)耳鼻喉科就诊的患者中口腔或口咽粘膜病变(OOPML)的发病率、流行病学概况和临床特征。方法对病历中的描述性数据(性别、年龄、教育程度、肤色、籍贯、吸烟、酗酒、HIV合并感染、疾病演变时间、首发症状和OOPML位置)进行统计分析。结果在7551名就诊患者中,有620人(8.2%)被纳入研究。OOPML分为发育异常(3例)、感染性疾病(非肉芽肿性220例;肉芽肿性155例)、自身免疫性疾病(24例)、肿瘤(良性13例;恶性103例)和未分类的上皮/软组织疾病(102例)。感染性疾病(60.5%)和肿瘤(18.7%)是最常见的 OOPML。OOPML患者的主要人口统计学特征为:男性(63.5%)、白人(53.5%)和五至六十岁的人群(43.3%)。局部疼痛(18.1%)和吞咽困难(15%)是报告最多的首发症状,OOPML 最常见的部位是腭扁桃体(28.5%)、硬腭(22.7%)和舌头(20.3%)。中位演变时间为三个月。结论感染性 OOPML 最为常见,这在传染病参考中心是意料之中的,因此在普通护理和/或牙科服务中可能较少见。由于口腔/咽部检查通常不包括在常规体检中,因此可能存在口腔/咽部MML报告不足的情况。口腔/咽部检查应由牙科医生和耳鼻喉科医生等专科医生进行,他们具有识别口腔黏膜病的专业知识,即使是初发/无症状病例也不例外。鉴于 OOPML 可表现为多种疾病,多学科团队可为诊断提供便利,从而有可能实现疾病的早期治疗,进而降低发病率并改善预后。使用标准化病历进行口腔/咽部系统检查可为鉴别诊断提供相关工具,并为新的临床流行病学研究提供信息。
{"title":"Oral and oropharyngeal mucosal lesions: clinical-epidemiological study of patients attended at a reference center for infectious diseases","authors":"Clarissa Souza Mota Reis ,&nbsp;João Gustavo Corrêa Reis ,&nbsp;Fátima Conceição-Silva ,&nbsp;Cláudia Maria Valete","doi":"10.1016/j.bjorl.2024.101396","DOIUrl":"10.1016/j.bjorl.2024.101396","url":null,"abstract":"<div><h3>Objective</h3><p>To determine the prevalence, epidemiological profile, and clinical characteristics of Oral or Oropharyngeal Mucosal Lesions (OOPML) in patients attended at the Otorhinolaryngology Service of the Evandro Chagas National Institute of Infectious Diseases (INI-FIOCRUZ) from 2005 to 2017.</p></div><div><h3>Methods</h3><p>Statistical analysis of descriptive data from medical records (gender, age, education level, skin color, origin, smoking, alcoholism, HIV co-infection, time of disease evolution, first symptom, and OOPML location) was performed.</p></div><div><h3>Results</h3><p>Of 7551 patients attended at the service, 620 (8.2%) were included in the study. OOPML were classified into developmental anomalies (n = 3), infectious diseases (non-granulomatous n = 220; granulomatous n = 155), autoimmune diseases (n = 24), neoplasms (benign n = 13; malignant, n = 103), and unclassified epithelial/soft tissue diseases (n = 102). OOPML of infectious diseases (60.5%) and neoplasms (18.7%) were the most frequent. The predominant demographics of patients with OOPML were: males (63.5%), white (53.5%), and those in the fifth to sixth decades of life (43.3%). Local pain (18.1%) and odynophagia (15%) were the most reported first symptoms, and the most frequent OOPML sites were the palatine tonsil (28.5%), hard palate (22.7%), and tongue (20.3%). The median evolution time was three months.</p></div><div><h3>Conclusions</h3><p>Infectious OOPML were the most frequent, as expected in a reference center for infectious diseases, and thus, they are likely to be less frequent in general care and/or dental services. Underreporting of OOPML is possible, as oral/oropharyngeal examination is often not included in the routine medical examination. Oral cavity/oropharynx examination should be performed by specialists, such as dentists and otorhinolaryngologists, who have the expertise in identifying OOPML, even in incipient/asymptomatic cases. Given the numerous diseases in which OOPML can present, diagnosis could be facilitated by multidisciplinary teams, potentially enabling the early treatment of diseases, and thus, reduce morbidity and improve prognosis. The use of standardized medical records for oral/oropharyngeal systematic examination could provide relevant tools for differential diagnoses and information for new clinical-epidemiological studies.</p></div><div><h3>Level of evidence</h3><p>Level 3.</p></div>","PeriodicalId":49099,"journal":{"name":"Brazilian Journal of Otorhinolaryngology","volume":null,"pages":null},"PeriodicalIF":2.2,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1808869424000119/pdfft?md5=42eb118cb2b9d137f5543cac42140625&pid=1-s2.0-S1808869424000119-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139668984","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Brazilian guideline for the use of immunobiologicals in chronic rhinosinusitis with nasal polyps ‒ 2024 update 巴西关于免疫生物制剂用于伴有鼻息肉的慢性鼻窦炎的指南--2024 年更新版
IF 2.2 4区 医学 Q2 Medicine Pub Date : 2024-01-30 DOI: 10.1016/j.bjorl.2024.101394
Wilma T. Anselmo-Lima , Fabrizio R. Romano , Edwin Tamashiro , Renato Roithmann , Vanessa R.P. Dinarte , Otavio B. Piltcher , Marcel M. Miyake , Marco A. Fornazieri , Marcio Nakanishi , Thiago F.P. Bezerra , Ricardo L.L. Dolci , João F. Mello Jr , Marcus M. Lessa , Richard L. Voegels , Eduardo M. Kosugi , Eulalia Sakano , Fabiana C.P. Valera

Introduction

Biologics targeting type 2 inflammation have revolutionized the way we treat patients with Chronic Rhinosinusitis with Nasal Polyps (CRSwNP). Particularly in severe and difficult-to-control cases, these drugs have provided a new reality for these patients, allowing for the effective and safe treatment of extensive diseases that were not completely managed with the typical strategy of surgery and topical medications.

Objectives

The experience achieved with the approval of these medications by ANVISA for use in CRSwNP and the knowledge obtained regarding outcomes, adverse effects, and the ideal patient profile prompted the update of the previously published guideline, with a detailed review of the most recent scientific literature, the personal experiences of experts, and the adaptation to the reality of the Brazilian healthcare system, both public and private.

Results

We proposed a new eligibility criterion for biologics in patients with CRSwNP based on four pillars of indication: the impact of the disease on the patient’s life, whether in the presence of specific symptoms or in overall quality of life; the extent of sinonasal disease; the presence of type 2 comorbidities, considering other associated diseases that may also benefit from anti-T2 biologics, and the presence of biomarkers to define type 2 inflammation, especially those associated with worse disease prognoses.

Conclusions

This innovative and pioneering method has two major advantages. First, it ensures a comprehensive evaluation of patients; second, it is flexible, as advancements in our understanding of the disease and changes in cost-effectiveness can be addressed by simply adjusting the required score for indication, without the need to modify the entire evaluation scheme.

引言 针对 2 型炎症的生物制剂彻底改变了我们治疗慢性鼻炎伴鼻息肉(CRSwNP)患者的方式。特别是在病情严重和难以控制的病例中,这些药物为这些患者提供了一个新的现实,使他们能够有效、安全地治疗广泛的疾病,而传统的手术和局部用药策略并不能完全控制这些疾病。目的ANVISA批准这些药物用于CRSwNP取得的经验,以及对疗效、不良反应和理想患者情况的了解,促使我们对之前发布的指南进行了更新,详细审查了最新的科学文献、专家的个人经验,并根据巴西公共和私营医疗系统的实际情况进行了调整。结果我们提出了 CRSwNP 患者使用生物制剂的新资格标准,该标准以四大适应症为基础:疾病对患者生活的影响,无论是特定症状还是整体生活质量;鼻窦疾病的程度;是否存在 2 型合并症,考虑到其他相关疾病也可能从抗 T2 生物制剂中获益,以及是否存在确定 2 型炎症的生物标志物,尤其是那些与疾病预后较差相关的生物标志物。首先,它能确保对患者进行全面评估;其次,它具有灵活性,因为我们对疾病认识的进步和成本效益的变化只需调整适应症所需的评分即可,而无需修改整个评估方案。
{"title":"Brazilian guideline for the use of immunobiologicals in chronic rhinosinusitis with nasal polyps ‒ 2024 update","authors":"Wilma T. Anselmo-Lima ,&nbsp;Fabrizio R. Romano ,&nbsp;Edwin Tamashiro ,&nbsp;Renato Roithmann ,&nbsp;Vanessa R.P. Dinarte ,&nbsp;Otavio B. Piltcher ,&nbsp;Marcel M. Miyake ,&nbsp;Marco A. Fornazieri ,&nbsp;Marcio Nakanishi ,&nbsp;Thiago F.P. Bezerra ,&nbsp;Ricardo L.L. Dolci ,&nbsp;João F. Mello Jr ,&nbsp;Marcus M. Lessa ,&nbsp;Richard L. Voegels ,&nbsp;Eduardo M. Kosugi ,&nbsp;Eulalia Sakano ,&nbsp;Fabiana C.P. Valera","doi":"10.1016/j.bjorl.2024.101394","DOIUrl":"10.1016/j.bjorl.2024.101394","url":null,"abstract":"<div><h3>Introduction</h3><p>Biologics targeting type 2 inflammation have revolutionized the way we treat patients with Chronic Rhinosinusitis with Nasal Polyps (CRSwNP). Particularly in severe and difficult-to-control cases, these drugs have provided a new reality for these patients, allowing for the effective and safe treatment of extensive diseases that were not completely managed with the typical strategy of surgery and topical medications.</p></div><div><h3>Objectives</h3><p>The experience achieved with the approval of these medications by ANVISA for use in CRSwNP and the knowledge obtained regarding outcomes, adverse effects, and the ideal patient profile prompted the update of the previously published guideline, with a detailed review of the most recent scientific literature, the personal experiences of experts, and the adaptation to the reality of the Brazilian healthcare system, both public and private.</p></div><div><h3>Results</h3><p>We proposed a new eligibility criterion for biologics in patients with CRSwNP based on four pillars of indication: the impact of the disease on the patient’s life, whether in the presence of specific symptoms or in overall quality of life; the extent of sinonasal disease; the presence of type 2 comorbidities, considering other associated diseases that may also benefit from anti-T2 biologics, and the presence of biomarkers to define type 2 inflammation, especially those associated with worse disease prognoses.</p></div><div><h3>Conclusions</h3><p>This innovative and pioneering method has two major advantages. First, it ensures a comprehensive evaluation of patients; second, it is flexible, as advancements in our understanding of the disease and changes in cost-effectiveness can be addressed by simply adjusting the required score for indication, without the need to modify the entire evaluation scheme.</p></div>","PeriodicalId":49099,"journal":{"name":"Brazilian Journal of Otorhinolaryngology","volume":null,"pages":null},"PeriodicalIF":2.2,"publicationDate":"2024-01-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1808869424000090/pdfft?md5=97d7aec3717eefb763a362c05b9c33a5&pid=1-s2.0-S1808869424000090-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139647082","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Anlotinib suppressed tumor cell proliferation and migration in hypopharyngeal carcinoma 安罗替尼抑制下咽癌的肿瘤细胞增殖和迁移
IF 2.2 4区 医学 Q2 Medicine Pub Date : 2024-01-25 DOI: 10.1016/j.bjorl.2024.101397
Hao Song , Qing Song , Xiangkun Zhao , Yuteng Yang , Yakui Mou , Yumei Li , Xicheng Song

Objective

The purpose of this study is to study the in-vitro effects of multitarget inhibitor anlotinib on hypopharyngeal cancer cell proliferation and cell migration, and the underlying mechanism, which will provide new drug choices for hypopharyngeal cancer treatment.

Methods

The Hypopharyngeal cancer Fadu cells were treated with anlotinib at a concentration of 0, 5, and 10 μmoL/L, respectively. Cell counting kit-8 and the colony-forming assay were used to detect the inhibition of cell proliferation. Wound-healing assay and transwell assay were used to detect the migration and invasion ability of cells. Flow cytometry was used to detect the effects of anlotinib on cell cycle and apoptosis. RT-qPCR and Western blot were used to measure gene expression levels.

Results

CCK-8 and colony-forming assay showed that anlotinib could significantly inhibit cell proliferative activity. Wound-healing assay and transwell assay showed that anlotinib could inhibit cell migration and scratch. These results showed that anlotinib has obvious antitumor activity. Flow cell cycle experiment showed that anlotinib could promote Fadu cell apoptosis and block the G2/M phase for inhibiting cell proliferation. In addition, anlotinib decreased the expression of HIF-1α.

Conclusions

Anlotinib has an excellent suppressing effect on the proliferation, migration, and invasion of hypopharyngeal cancer Fadu cells in-vitro. Moreover, it can play an anti-tumor role through blocking cell cycle G2/M and promoting apoptosis, which may be related to the decrease of HIF-1a expression. Our study would provide a potential treatment method for patients with hypopharyngeal cancer.

Level of evidence

Level 3.

目的研究多靶点抑制剂安罗替尼对下咽癌细胞增殖和迁移的体外效应及其机制,为下咽癌治疗提供新的药物选择。方法分别用0、5和10 µmoL/L浓度的安罗替尼处理下咽癌Fadu细胞。采用细胞计数试剂盒-8 和集落形成试验检测对细胞增殖的抑制作用。伤口愈合试验和透孔试验用于检测细胞的迁移和侵袭能力。流式细胞术用于检测安罗替尼对细胞周期和细胞凋亡的影响。结果CCK-8和集落形成试验表明,安罗替尼能显著抑制细胞增殖活性。伤口愈合试验和透孔试验表明,安罗替尼可抑制细胞迁移和划痕。这些结果表明,安罗替尼具有明显的抗肿瘤活性。流式细胞周期实验表明,安罗替尼可促进法杜细胞凋亡,阻断G2/M期以抑制细胞增殖。结论安罗替尼对下咽癌Fadu细胞的体外增殖、迁移和侵袭有很好的抑制作用。此外,它还能通过阻滞细胞周期G2/M和促进细胞凋亡发挥抗肿瘤作用,这可能与HIF-1a的表达减少有关。我们的研究将为下咽癌患者提供一种潜在的治疗方法。
{"title":"Anlotinib suppressed tumor cell proliferation and migration in hypopharyngeal carcinoma","authors":"Hao Song ,&nbsp;Qing Song ,&nbsp;Xiangkun Zhao ,&nbsp;Yuteng Yang ,&nbsp;Yakui Mou ,&nbsp;Yumei Li ,&nbsp;Xicheng Song","doi":"10.1016/j.bjorl.2024.101397","DOIUrl":"10.1016/j.bjorl.2024.101397","url":null,"abstract":"<div><h3>Objective</h3><p>The purpose of this study is to study the in-vitro effects of multitarget inhibitor anlotinib on hypopharyngeal cancer cell proliferation and cell migration, and the underlying mechanism, which will provide new drug choices for hypopharyngeal cancer treatment.</p></div><div><h3>Methods</h3><p>The Hypopharyngeal cancer Fadu cells were treated with anlotinib at a concentration of 0, 5, and 10 μmoL/L, respectively. Cell counting kit-8 and the colony-forming assay were used to detect the inhibition of cell proliferation. Wound-healing assay and transwell assay were used to detect the migration and invasion ability of cells. Flow cytometry was used to detect the effects of anlotinib on cell cycle and apoptosis. RT-qPCR and Western blot were used to measure gene expression levels.</p></div><div><h3>Results</h3><p>CCK-8 and colony-forming assay showed that anlotinib could significantly inhibit cell proliferative activity. Wound-healing assay and transwell assay showed that anlotinib could inhibit cell migration and scratch. These results showed that anlotinib has obvious antitumor activity. Flow cell cycle experiment showed that anlotinib could promote Fadu cell apoptosis and block the G2/M phase for inhibiting cell proliferation. In addition, anlotinib decreased the expression of HIF-1α.</p></div><div><h3>Conclusions</h3><p>Anlotinib has an excellent suppressing effect on the proliferation, migration, and invasion of hypopharyngeal cancer Fadu cells in-vitro. Moreover, it can play an anti-tumor role through blocking cell cycle G2/M and promoting apoptosis, which may be related to the decrease of HIF-1a expression. Our study would provide a potential treatment method for patients with hypopharyngeal cancer.</p></div><div><h3>Level of evidence</h3><p>Level 3.</p></div>","PeriodicalId":49099,"journal":{"name":"Brazilian Journal of Otorhinolaryngology","volume":null,"pages":null},"PeriodicalIF":2.2,"publicationDate":"2024-01-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1808869424000120/pdfft?md5=3c80082aaec3249e3486764da20c0d47&pid=1-s2.0-S1808869424000120-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139580867","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Immunoglobulin-G4 laryngitis with co-existing Peyronie’s disease 免疫球蛋白-G4 喉炎并发佩罗尼氏病
IF 2.2 4区 医学 Q2 Medicine Pub Date : 2024-01-25 DOI: 10.1016/j.bjorl.2024.101395
Shivanchan Rajmohan , Chuanyu Gao , Kajaanan Rajmohan , Shivun Khosla , Lisa Pitkin
{"title":"Immunoglobulin-G4 laryngitis with co-existing Peyronie’s disease","authors":"Shivanchan Rajmohan ,&nbsp;Chuanyu Gao ,&nbsp;Kajaanan Rajmohan ,&nbsp;Shivun Khosla ,&nbsp;Lisa Pitkin","doi":"10.1016/j.bjorl.2024.101395","DOIUrl":"10.1016/j.bjorl.2024.101395","url":null,"abstract":"","PeriodicalId":49099,"journal":{"name":"Brazilian Journal of Otorhinolaryngology","volume":null,"pages":null},"PeriodicalIF":2.2,"publicationDate":"2024-01-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1808869424000107/pdfft?md5=8de2f5132ecf18621a4997019ee010b7&pid=1-s2.0-S1808869424000107-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139558791","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Additional cognitive behavior therapy for persistent postural-perceptual dizziness: a meta-analysis 针对持续性姿势感知性头晕的额外认知行为疗法:荟萃分析
IF 2.2 4区 医学 Q2 Medicine Pub Date : 2024-01-24 DOI: 10.1016/j.bjorl.2024.101393
Jialin Zang , Mohan Zheng , Hongyuan Chu , Xu Yang

Objective

To investigate whether additional Cognitive Behavior Therapy (CBT) combined with conventional therapy improves outcomes for patients with Persistent Postural-Perceptual Dizziness (PPPD) compared with conventional therapy alone.

Methods

Two reviewers independently searched PubMed, Embase, Web of Science, Cochrane Library, and ClinicalTrials.gov for relevant Randomized Controlled Trials (RCTs) examining CBT for PPPD which were conducted and published in English from January 2002 to November 2022. RCTs reporting any indicators for assessing corresponding symptoms of PPPD were included, such as Dizziness Handicap Inventory (DHI), Hamilton Anxiety Scale (HAMA), Hamilton Depression Scale (HAMD), Hospital Anxiety and Depression Scale (HADS), and Patient Health Questionnaire-9 (PHQ-9). Two independent reviewers conducted extraction of relevant information and evaluation of risk of bias. The Cochrane Collaboration risk of bias tool version 1.0 was used to evaluate risks and assess the quality of the included studies, and Cochrane Review Manager 5.3 software (RevMan 5.3) was used to perform meta-analyses.

Results

The results of six RCTs indicated that combining additional CBT with conventional therapy significantly improved outcomes for PPPD patients compared with conventional therapy alone, especially in DHI-Total scores (Mean Difference [MD = −8.17], 95% Confidence Interval [95% CI: −10.26, −6.09], p < 0.00001), HAMA scores (MD = −2.76, 95% CI: [−3.57, −1.94], p < 0.00001), GAD-7 scores (MD = −2.50, 95% CI [−3.29, −1.70], p < 0.00001), and PHQ-9 scores (MD = −2.29, 95% CI [−3.04, −1.55], p < 0.00001). Subgroup analysis revealed a significant benefit of additional CBT compared with conventional therapies alone, including Vestibular Rehabilitation Therapy (VRT) (MD = −8.70, 95% CI: [−12.17, −5.22], p < 0.00001), Selective Serotonin Reuptake Inhibitor (SSRI) (with controlled SSRI: MD = −10.70, 95% CI: [−14.97, −6.43], p < 0.00001), and VRT combined with SSRI (MD = −6.08, 95% CI [−9.49, −2.67], p = 0.0005) in DHI-Total scores.

Conclusion

Additional CBT combined with conventional therapy may provide additional improvement for patients with PPPD compared with conventional therapy alone. However, more RCTs are needed to support and guide the application of CBT in treating PPPD.

Level of evidence

I; Systematic review of RCTs.

方法两位审稿人独立检索了PubMed、Embase、Web of Science、Cochrane Library和ClinicalTrials.gov等网站上2002年1月至2022年11月期间用英语进行并发表的、研究CBT治疗PPPD的相关随机对照试验(RCT)。纳入了报告任何评估 PPPD 相应症状指标的 RCT,如头晕障碍量表 (DHI)、汉密尔顿焦虑量表 (HAMA)、汉密尔顿抑郁量表 (HAMD)、医院焦虑抑郁量表 (HADS) 和患者健康问卷-9 (PHQ-9)。两名独立审稿人负责提取相关信息并评估偏倚风险。结果六项 RCT 的研究结果表明,与单独使用传统疗法相比,将额外的 CBT 与传统疗法相结合可显著改善 PPPD 患者的治疗效果,尤其是在 DHI-总分方面(平均差 [MD = -8.17], 95% Confidence Interval [95% CI: -10.26, -6.09], p < 0.00001)、HAMA 评分(MD = -2.76, 95% CI: [-3.57, -1.94], p < 0.00001)、GAD-7 评分(MD = -2.50,95% CI [-3.29,-1.70],p < 0.00001)和 PHQ-9 评分(MD = -2.29,95% CI [-3.04,-1.55],p < 0.00001)。亚组分析显示,与单纯的传统疗法相比,额外的 CBT 有明显的益处,包括前庭康复疗法(VRT)(MD = -8.70,95% CI:[-12.17,-5.22],p < 0.00001)、选择性羟色胺再摄取抑制剂(SSRI)(控制 SSRI:MD = -10.70,95% CI:[-14.97,-6.43],p <0.00001),以及 VRT 联合 SSRI(MD = -6.08,95% CI [-9.49,-2.67],p = 0.0005)的 DHI-Total 评分。然而,需要更多的 RCT 来支持和指导 CBT 在治疗 PPPD 中的应用。
{"title":"Additional cognitive behavior therapy for persistent postural-perceptual dizziness: a meta-analysis","authors":"Jialin Zang ,&nbsp;Mohan Zheng ,&nbsp;Hongyuan Chu ,&nbsp;Xu Yang","doi":"10.1016/j.bjorl.2024.101393","DOIUrl":"10.1016/j.bjorl.2024.101393","url":null,"abstract":"<div><h3>Objective</h3><p>To investigate whether additional Cognitive Behavior Therapy (CBT) combined with conventional therapy improves outcomes for patients with Persistent Postural-Perceptual Dizziness (PPPD) compared with conventional therapy alone.</p></div><div><h3>Methods</h3><p>Two reviewers independently searched PubMed, Embase, Web of Science, Cochrane Library, and ClinicalTrials.gov for relevant Randomized Controlled Trials (RCTs) examining CBT for PPPD which were conducted and published in English from January 2002 to November 2022. RCTs reporting any indicators for assessing corresponding symptoms of PPPD were included, such as Dizziness Handicap Inventory (DHI), Hamilton Anxiety Scale (HAMA), Hamilton Depression Scale (HAMD), Hospital Anxiety and Depression Scale (HADS), and Patient Health Questionnaire-9 (PHQ-9). Two independent reviewers conducted extraction of relevant information and evaluation of risk of bias. The Cochrane Collaboration risk of bias tool version 1.0 was used to evaluate risks and assess the quality of the included studies, and Cochrane Review Manager 5.3 software (RevMan 5.3) was used to perform meta-analyses.</p></div><div><h3>Results</h3><p>The results of six RCTs indicated that combining additional CBT with conventional therapy significantly improved outcomes for PPPD patients compared with conventional therapy alone, especially in DHI-Total scores (Mean Difference [MD = −8.17], 95% Confidence Interval [95% CI: −10.26, −6.09], <em>p</em> &lt; 0.00001), HAMA scores (MD = −2.76, 95% CI: [−3.57, −1.94], <em>p</em> &lt; 0.00001), GAD-7 scores (MD = −2.50, 95% CI [−3.29, −1.70], <em>p</em> &lt; 0.00001), and PHQ-9 scores (MD = −2.29, 95% CI [−3.04, −1.55], <em>p</em> &lt; 0.00001). Subgroup analysis revealed a significant benefit of additional CBT compared with conventional therapies alone, including Vestibular Rehabilitation Therapy (VRT) (MD = −8.70, 95% CI: [−12.17, −5.22], <em>p</em> &lt; 0.00001), Selective Serotonin Reuptake Inhibitor (SSRI) (with controlled SSRI: MD = −10.70, 95% CI: [−14.97, −6.43], <em>p</em> &lt; 0.00001), and VRT combined with SSRI (MD = −6.08, 95% CI [−9.49, −2.67], <em>p</em> = 0.0005) in DHI-Total scores.</p></div><div><h3>Conclusion</h3><p>Additional CBT combined with conventional therapy may provide additional improvement for patients with PPPD compared with conventional therapy alone. However, more RCTs are needed to support and guide the application of CBT in treating PPPD.</p></div><div><h3>Level of evidence</h3><p>I; Systematic review of RCTs.</p></div>","PeriodicalId":49099,"journal":{"name":"Brazilian Journal of Otorhinolaryngology","volume":null,"pages":null},"PeriodicalIF":2.2,"publicationDate":"2024-01-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1808869424000089/pdfft?md5=69c4e5914c5734968548976a6bd01ffa&pid=1-s2.0-S1808869424000089-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139558666","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Necrotizing sialometaplasia on the hard palate after sequential induced vomiting: case study 连续诱导呕吐后硬腭上的坏死性牙骨质增生症:病例研究
IF 2.2 4区 医学 Q2 Medicine Pub Date : 2023-12-28 DOI: 10.1016/j.bjorl.2023.101385
Elaine Costa , Gabriel Caetano de Jesus , Bruno Siqueira Bellini , Ana Cristina Coelho Dal Rio Teixeira
{"title":"Necrotizing sialometaplasia on the hard palate after sequential induced vomiting: case study","authors":"Elaine Costa ,&nbsp;Gabriel Caetano de Jesus ,&nbsp;Bruno Siqueira Bellini ,&nbsp;Ana Cristina Coelho Dal Rio Teixeira","doi":"10.1016/j.bjorl.2023.101385","DOIUrl":"10.1016/j.bjorl.2023.101385","url":null,"abstract":"","PeriodicalId":49099,"journal":{"name":"Brazilian Journal of Otorhinolaryngology","volume":null,"pages":null},"PeriodicalIF":2.2,"publicationDate":"2023-12-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1808869423001532/pdfft?md5=54c324a93f7e454bed183091f73abfd8&pid=1-s2.0-S1808869423001532-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139068300","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effective prognostic risk model with cuproptosis-related genes in laryngeal cancer 利用杯突相关基因建立有效的喉癌预后风险模型
IF 2.2 4区 医学 Q2 Medicine Pub Date : 2023-12-26 DOI: 10.1016/j.bjorl.2023.101384
Cong Li , Yongzhi Zhu , Song Shi

Objective

Laryngeal cancer, characterized by high recurrence rates and a lack of effective biomarkers, has been associated with cuproptosis, a regulated cell death process linked to cancer progression. In this study, we aimed to explore the roles of cuproptosis-related genes in laryngeal cancer and their potential as prognostic markers and therapeutic targets.

Methods

We collected comprehensive data from The Cancer Genome Atlas and Gene Expression Omnibus databases, including gene expression profiles and clinical data of laryngeal cancer patients. Using clustering and gene analysis, we identified cuproptosis-related genes with prognostic significance. A risk model was constructed based on these genes, categorizing patients into high- and low-risk groups for outcome comparison. Univariate and multivariate analyses were conducted to identify independent prognostic factors, which were then incorporated into a nomogram. Gene Set Enrichment Analysis was employed to explore pathways distinguishing high- and low-risk groups.

Results

Our risk model, based on four genes, including transmembrane 2, dishevelled binding antagonist of β-catenin 1, stathmin 2, and G protein-coupled receptor 173, revealed significant differences in patient outcomes between high- and low-risk groups. Independent prognostic factors were identified and integrated into a nomogram, providing a valuable tool for prognostic prediction. Gene Set Enrichment Analysis uncovered up-regulated pathways specifically associated with high-risk patient samples.

Conclusion

This study highlights the potential of cuproptosis-related genes as valuable prognostic markers and promising therapeutic targets in the context of laryngeal cancer. This research sheds light on new avenues for understanding and managing this challenging disease.

Level of evidence

Level 4.

目的 喉癌的特点是复发率高且缺乏有效的生物标志物,它与杯突症有关,杯突症是一种与癌症进展相关的细胞死亡调节过程。本研究旨在探索杯突相关基因在喉癌中的作用及其作为预后标志物和治疗靶点的潜力。方法我们从癌症基因组图谱(The Cancer Genome Atlas)和基因表达总库(Gene Expression Omnibus)数据库中收集了全面的数据,包括喉癌患者的基因表达谱和临床数据。通过聚类和基因分析,我们发现了具有预后意义的杯突症相关基因。根据这些基因构建了一个风险模型,将患者分为高风险组和低风险组,以便进行结果比较。通过单变量和多变量分析确定了独立的预后因素,并将其纳入提名图。结果我们的风险模型基于四个基因,包括跨膜 2、β-catenin 1 的脱落结合拮抗剂、stathmin 2 和 G 蛋白偶联受体 173,发现高危组和低危组患者的预后存在显著差异。鉴定出了独立的预后因素,并将其整合到一个提名图中,为预后预测提供了有价值的工具。基因组富集分析(Gene Set Enrichment Analysis)发现了与高风险患者样本特别相关的上调通路。这项研究为了解和管理这种具有挑战性的疾病提供了新的途径。
{"title":"Effective prognostic risk model with cuproptosis-related genes in laryngeal cancer","authors":"Cong Li ,&nbsp;Yongzhi Zhu ,&nbsp;Song Shi","doi":"10.1016/j.bjorl.2023.101384","DOIUrl":"10.1016/j.bjorl.2023.101384","url":null,"abstract":"<div><h3>Objective</h3><p>Laryngeal cancer, characterized by high recurrence rates and a lack of effective biomarkers, has been associated with cuproptosis, a regulated cell death process linked to cancer progression. In this study, we aimed to explore the roles of cuproptosis-related genes in laryngeal cancer and their potential as prognostic markers and therapeutic targets.</p></div><div><h3>Methods</h3><p>We collected comprehensive data from The Cancer Genome Atlas and Gene Expression Omnibus databases, including gene expression profiles and clinical data of laryngeal cancer patients. Using clustering and gene analysis, we identified cuproptosis-related genes with prognostic significance. A risk model was constructed based on these genes, categorizing patients into high- and low-risk groups for outcome comparison. Univariate and multivariate analyses were conducted to identify independent prognostic factors, which were then incorporated into a nomogram. Gene Set Enrichment Analysis was employed to explore pathways distinguishing high- and low-risk groups.</p></div><div><h3>Results</h3><p>Our risk model, based on four genes, including transmembrane 2, dishevelled binding antagonist of β-catenin 1, stathmin 2, and G protein-coupled receptor 173, revealed significant differences in patient outcomes between high- and low-risk groups. Independent prognostic factors were identified and integrated into a nomogram, providing a valuable tool for prognostic prediction. Gene Set Enrichment Analysis uncovered up-regulated pathways specifically associated with high-risk patient samples.</p></div><div><h3>Conclusion</h3><p>This study highlights the potential of cuproptosis-related genes as valuable prognostic markers and promising therapeutic targets in the context of laryngeal cancer. This research sheds light on new avenues for understanding and managing this challenging disease.</p></div><div><h3>Level of evidence</h3><p>Level 4.</p></div>","PeriodicalId":49099,"journal":{"name":"Brazilian Journal of Otorhinolaryngology","volume":null,"pages":null},"PeriodicalIF":2.2,"publicationDate":"2023-12-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1808869423001520/pdfft?md5=fb94ed3fc8840b4163564f9320a0720f&pid=1-s2.0-S1808869423001520-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139056492","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Detailed analysis of inner ear malformations in CHARGE syndrome patients – correlation with audiological results and proposal for computed tomography scans evaluation methodology CHARGE 综合征患者内耳畸形的详细分析--与听力结果的相关性及计算机断层扫描评估方法的建议
IF 2.2 4区 医学 Q2 Medicine Pub Date : 2023-12-23 DOI: 10.1016/j.bjorl.2023.101383
Agata Szleper , Magdalena Lachowska , Tomasz Wojciechowski , Katarzyna Pronicka-Iwanicka

Objectives

The aim was to describe the spectrum of inner ear malformations in CHARGE syndrome and propose a Computed Tomography (CT) detailed scan evaluation methodology. The secondary aim was to correlate the CT findings with hearing thresholds.

Methods

Twenty ears of ten patients diagnosed with CHARGE syndrome were subjected to CT analysis focusing on the inner ear and internal acoustic canal. The protocol used is presented in detail. ASSR results were analyzed and correlated with inner ear malformations.

Results

Cochlear hypoplasia type III was the most common malformation found in 12 ears (60%). Cochlear hypoplasia type II, aplasia with a dilated vestibule, and rudimentary otocyst were also identified. In 20%, no cochlear anomaly was found. The lateral Semicircular Canal (SCC) absence affected 100% of ears, the absence of the posterior SCC 95%, and the superior SCC 65%. Better development of cochlea structures and IAC correlated significantly with the lower hearing thresholds.

Conclusion

This study demonstrated that rudimentary SCC or a complete absence of these SCCs was universally observed in all patients diagnosed with CHARGE syndrome. This finding supports the idea that inner ear anomalies are a hallmark feature of the CHARGE, contributing to its distinct clinical profile. The presence of inner ear malformations has substantial clinical implications. Audiological assessments are crucial for CHARGE syndrome, as hearing loss is common. Early detection of these malformations can guide appropriate interventions, such as hearing aids or cochlear implants, which may significantly improve developmental outcomes and communication for affected individuals. Recognizing inner ear malformations as a diagnostic criterion presents implications beyond clinical diagnosis. A better understanding of these malformations can advance the knowledge of CHARGE pathophysiology. It may also help guide future research into targeted therapies to mitigate the impact of inner ear anomalies on hearing and balance function.

Level of evidence

4.

目的描述 CHARGE 综合征内耳畸形的范围,并提出计算机断层扫描 (CT) 详细扫描评估方法。方法对确诊为 CHARGE 综合征的十名患者的二十只耳朵进行 CT 分析,重点是内耳和内听道。详细介绍了使用的方案。对 ASSR 结果进行了分析,并将其与内耳畸形相关联。结果12 只耳朵(60%)中最常见的畸形是耳蜗发育不良 III 型。此外,还发现了耳蜗发育不全 II 型、前庭扩张发育不全和耳囊不发育。20%的患者未发现耳蜗异常。外侧半规管(SCC)缺失影响了100%的耳朵,后侧半规管缺失影响了95%的耳朵,上侧半规管缺失影响了65%的耳朵。耳蜗结构和内耳道发育较好与听阈较低密切相关。这一发现支持了内耳畸形是 CHARGE 综合征的标志性特征这一观点,从而导致了其独特的临床特征。内耳畸形的存在具有重要的临床意义。听力评估对 CHARGE 综合征至关重要,因为听力损失很常见。及早发现这些畸形可指导采取适当的干预措施,如佩戴助听器或植入人工耳蜗,从而显著改善患者的发育成果和沟通能力。将内耳畸形作为诊断标准的意义超出了临床诊断。更好地了解这些畸形可促进对 CHARGE 病理生理学的了解。它还有助于指导未来的靶向疗法研究,以减轻内耳畸形对听力和平衡功能的影响。
{"title":"Detailed analysis of inner ear malformations in CHARGE syndrome patients – correlation with audiological results and proposal for computed tomography scans evaluation methodology","authors":"Agata Szleper ,&nbsp;Magdalena Lachowska ,&nbsp;Tomasz Wojciechowski ,&nbsp;Katarzyna Pronicka-Iwanicka","doi":"10.1016/j.bjorl.2023.101383","DOIUrl":"10.1016/j.bjorl.2023.101383","url":null,"abstract":"<div><h3>Objectives</h3><p>The aim was to describe the spectrum of inner ear malformations in CHARGE syndrome and propose a Computed Tomography (CT) detailed scan evaluation methodology. The secondary aim was to correlate the CT findings with hearing thresholds.</p></div><div><h3>Methods</h3><p>Twenty ears of ten patients diagnosed with CHARGE syndrome were subjected to CT analysis focusing on the inner ear and internal acoustic canal. The protocol used is presented in detail. ASSR results were analyzed and correlated with inner ear malformations.</p></div><div><h3>Results</h3><p>Cochlear hypoplasia type III was the most common malformation found in 12 ears (60%). Cochlear hypoplasia type II, aplasia with a dilated vestibule, and rudimentary otocyst were also identified. In 20%, no cochlear anomaly was found. The lateral Semicircular Canal (SCC) absence affected 100% of ears, the absence of the posterior SCC 95%, and the superior SCC 65%. Better development of cochlea structures and IAC correlated significantly with the lower hearing thresholds.</p></div><div><h3>Conclusion</h3><p>This study demonstrated that rudimentary SCC or a complete absence of these SCCs was universally observed in all patients diagnosed with CHARGE syndrome. This finding supports the idea that inner ear anomalies are a hallmark feature of the CHARGE, contributing to its distinct clinical profile. The presence of inner ear malformations has substantial clinical implications. Audiological assessments are crucial for CHARGE syndrome, as hearing loss is common. Early detection of these malformations can guide appropriate interventions, such as hearing aids or cochlear implants, which may significantly improve developmental outcomes and communication for affected individuals. Recognizing inner ear malformations as a diagnostic criterion presents implications beyond clinical diagnosis. A better understanding of these malformations can advance the knowledge of CHARGE pathophysiology. It may also help guide future research into targeted therapies to mitigate the impact of inner ear anomalies on hearing and balance function.</p></div><div><h3>Level of evidence</h3><p>4.</p></div>","PeriodicalId":49099,"journal":{"name":"Brazilian Journal of Otorhinolaryngology","volume":null,"pages":null},"PeriodicalIF":2.2,"publicationDate":"2023-12-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1808869423001519/pdfft?md5=1a40bb95c48556d02ea8656463431581&pid=1-s2.0-S1808869423001519-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139030233","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Thermal variation in human temporal bone using rigid endoscope 使用刚性内窥镜观察人体颞骨的热变化
IF 2.2 4区 医学 Q2 Medicine Pub Date : 2023-12-19 DOI: 10.1016/j.bjorl.2023.101381
Thales Xavit Souza e Silva, Aline Bruno Figueiredo Nicolau, Marcos Luiz Antunes

Objective

Compare thermal variation in the region of the External Acoustic Canal (EAC) and the Round Window (RW) using different rigid endoscopes and light sources in human temporal bones.

Method

This is an analytical experimental study using human temporal bones. Thermal variation was assessed during ten minutes, using a thermometer in the region of the EAC and the RW of two temporal bones, right and left. We used three different endoscopes (0° 4-mm, 0° 3-mm and 30° 4-mm) and five intensity/type light source (Halogen 100%, LED 50%, LED 100%, Xenon 50% and Xenon 100% with the same endoscope light fiber.

Results

We found temperature elevations in the EAC and RW in all measurements. Larger caliber endoscopes (4-mm) and light sources at 100% intensity generated higher temperatures, slightly higher in halogen and xenon. The 30° endoscopes tended to put more heat on structures, with little difference in most measurements. We identified greater temperature variations in the EAC of the right and left temporal bones compared to the RW overall. The highest temperature acquired in the present study was in the EAC of the temporal bone with a 4-mm and 30° endoscope, using xenon light source (intensity of 100%), with an increase of 4.51 °C.

Conclusion

The type of endoscope and light source can influence the thermal variation and the risk of tissue injury during endoscopic ear surgery. Larger endoscopes with xenon and halogen light sources at maximum intensity generate more heat.

Level of evidence

5.

目的使用不同的刚性内窥镜和光源比较人颞骨外耳道(EAC)和圆窗(RW)区域的热变化。 方法这是一项使用人颞骨进行的分析实验研究。使用温度计对左右两块颞骨的外耳道和圆窗区域进行了十分钟的热变化评估。我们使用了三种不同的内窥镜(0° 4 毫米、0° 3 毫米和 30° 4 毫米)和五种强度/类型的光源(卤素灯 100%、LED 50%、LED 100%、氙灯 50%和氙灯 100%,使用相同的内窥镜光纤维)。较大口径的内窥镜(4 毫米)和 100% 强度的光源产生的温度较高,卤素灯和氙灯的温度略高。30° 的内窥镜往往会对结构产生更多热量,但在大多数测量中差别不大。与 RW 整体相比,我们发现左右颞骨 EAC 的温度变化更大。结论内窥镜和光源的类型会影响耳内窥镜手术中的热变化和组织损伤风险。使用氙灯和卤素灯光源的大型内窥镜在最大强度下会产生更多热量。
{"title":"Thermal variation in human temporal bone using rigid endoscope","authors":"Thales Xavit Souza e Silva,&nbsp;Aline Bruno Figueiredo Nicolau,&nbsp;Marcos Luiz Antunes","doi":"10.1016/j.bjorl.2023.101381","DOIUrl":"10.1016/j.bjorl.2023.101381","url":null,"abstract":"<div><h3>Objective</h3><p>Compare thermal variation in the region of the External Acoustic Canal (EAC) and the Round Window (RW) using different rigid endoscopes and light sources in human temporal bones.</p></div><div><h3>Method</h3><p>This is an analytical experimental study using human temporal bones. Thermal variation was assessed during ten minutes, using a thermometer in the region of the EAC and the RW of two temporal bones, right and left. We used three different endoscopes (0° 4-mm, 0° 3-mm and 30° 4-mm) and five intensity/type light source (Halogen 100%, LED 50%, LED 100%, Xenon 50% and Xenon 100% with the same endoscope light fiber.</p></div><div><h3>Results</h3><p>We found temperature elevations in the EAC and RW in all measurements. Larger caliber endoscopes (4-mm) and light sources at 100% intensity generated higher temperatures, slightly higher in halogen and xenon. The 30° endoscopes tended to put more heat on structures, with little difference in most measurements. We identified greater temperature variations in the EAC of the right and left temporal bones compared to the RW overall. The highest temperature acquired in the present study was in the EAC of the temporal bone with a 4-mm and 30° endoscope, using xenon light source (intensity of 100%), with an increase of 4.51 °C.</p></div><div><h3>Conclusion</h3><p>The type of endoscope and light source can influence the thermal variation and the risk of tissue injury during endoscopic ear surgery. Larger endoscopes with xenon and halogen light sources at maximum intensity generate more heat.</p></div><div><h3>Level of evidence</h3><p>5.</p></div>","PeriodicalId":49099,"journal":{"name":"Brazilian Journal of Otorhinolaryngology","volume":null,"pages":null},"PeriodicalIF":2.2,"publicationDate":"2023-12-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1808869423001490/pdfft?md5=bcaab238dfefca3bc1717b22cce2b9c9&pid=1-s2.0-S1808869423001490-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138741775","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
One simple question detects motion sickness susceptibility in migraine patients 一个简单的问题就能检测出偏头痛患者的晕动病易感性
IF 2.2 4区 医学 Q2 Medicine Pub Date : 2023-12-19 DOI: 10.1016/j.bjorl.2023.101382
Gülden Akdal , Pınar Özçelik , Birgül Balcı , Gábor Michael Halmágyi , Belgin Ünal

Objective

To find out if motion sickness susceptibility (MSS) of vestibular migraine (VM) patients and migraine only (MO) patients can be reliably detected with a single simple question: “Can you read while travelling in a car without getting motion sick?”.

Method

Ninety-two definite VM and 58 MO patients and 74 healthy control (HC) subjects were asked about their MSS and about being able to read while riding in a car without becoming motion sick. A Motion Sickness Susceptibility Questionnaire (MSSQ-Short) including childhood (MSA), adulthood (MSB) and total (MST) parts was also administered to all participants. ROC curves of MSSQ-Short were prepared for “not being able to read in a car” as the gold standard.

Results

Mean MSA scores were significantly higher in both VM and MO patients than in HCs (p < 0.001), but their scores were not significantly different (p = 0.171). Mean MSB and MST scores were significantly higher in VM than in MO patients (p < 0.001) and both VM and MO patients had significantly higher scores than HCs (p < 0.001). MSA scores were significantly higher than MSB scores in MO patients (p < 0.001). All sections of the questionnaire were associated with high area-under-curve values for MSS detected by the question about being able to read in a car without becoming motion sick.

Conclusion

We propose that all migraine patients could have the same level of MSS in childhood but MO patients are able to compensate over years, but VM patients are not. A quick way to determine MSS is to ask about the ability to read without becoming motion sickness while riding a car.

目的 通过一个简单的问题,了解能否可靠地检测出前庭性偏头痛(VM)患者和单纯性偏头痛(MO)患者的晕车敏感性(MSS):"方法向92名明确的前庭性偏头痛(VM)患者、58名单纯偏头痛(MO)患者和74名健康对照组(HC)受试者询问他们的晕动病易感性(MSS),以及在乘车时能否阅读而不晕车。所有受试者都接受了晕车易感性问卷(MSSQ-Short),其中包括儿童期(MSA)、成年期(MSB)和总分(MST)三个部分。以 "无法在汽车中阅读 "作为金标准,绘制了 MSSQ-Short 的 ROC 曲线。结果 VM 和 MO 患者的平均 MSA 分数显著高于 HC(p <0.001),但他们的分数没有显著差异(p = 0.171)。VM 患者的 MSB 和 MST 平均得分显著高于 MO 患者(p < 0.001),VM 和 MO 患者的得分显著高于 HC 患者(p < 0.001)。MO患者的MSA评分明显高于MSB评分(p <0.001)。调查问卷的所有部分都与 "能否在车内阅读而不晕车 "这一问题所检测到的高MSS曲线下面积值相关。判断MSS的快速方法是询问患者是否能够在乘车时阅读而不晕车。
{"title":"One simple question detects motion sickness susceptibility in migraine patients","authors":"Gülden Akdal ,&nbsp;Pınar Özçelik ,&nbsp;Birgül Balcı ,&nbsp;Gábor Michael Halmágyi ,&nbsp;Belgin Ünal","doi":"10.1016/j.bjorl.2023.101382","DOIUrl":"10.1016/j.bjorl.2023.101382","url":null,"abstract":"<div><h3>Objective</h3><p>To find out if motion sickness susceptibility (MSS) of vestibular migraine (VM) patients and migraine only (MO) patients can be reliably detected with a single simple question: “Can you read while travelling in a car without getting motion sick?”.</p></div><div><h3>Method</h3><p>Ninety-two definite VM and 58 MO patients and 74 healthy control (HC) subjects were asked about their MSS and about being able to read while riding in a car without becoming motion sick. A Motion Sickness Susceptibility Questionnaire (MSSQ-Short) including childhood (MSA), adulthood (MSB) and total (MST) parts was also administered to all participants. ROC curves of MSSQ-Short were prepared for “not being able to read in a car” as the gold standard.</p></div><div><h3>Results</h3><p>Mean MSA scores were significantly higher in both VM and MO patients than in HCs (<em>p</em> &lt; 0.001), but their scores were not significantly different (<em>p</em> = 0.171). Mean MSB and MST scores were significantly higher in VM than in MO patients (<em>p</em> &lt; 0.001) and both VM and MO patients had significantly higher scores than HCs (<em>p</em> &lt; 0.001). MSA scores were significantly higher than MSB scores in MO patients (<em>p</em> &lt; 0.001). All sections of the questionnaire were associated with high area-under-curve values for MSS detected by the question about being able to read in a car without becoming motion sick.</p></div><div><h3>Conclusion</h3><p>We propose that all migraine patients could have the same level of MSS in childhood but MO patients are able to compensate over years, but VM patients are not. A quick way to determine MSS is to ask about the ability to read without becoming motion sickness while riding a car.</p></div>","PeriodicalId":49099,"journal":{"name":"Brazilian Journal of Otorhinolaryngology","volume":null,"pages":null},"PeriodicalIF":2.2,"publicationDate":"2023-12-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1808869423001507/pdfft?md5=2bd216b01b6e20c46dfdf03b18ff1f1d&pid=1-s2.0-S1808869423001507-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138741588","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Brazilian Journal of Otorhinolaryngology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1